Asuragen's Series A - II Round

Asuragen raised a round of funding on October 23, 2007. Investors include Merck Global Health Innovation Fund.

Asuragen is a fully integrated molecular diagnostics company focused on oncology and companion diagnostics with special capabilities in the area of mRNA and miRNA. Based in Austin, Texas, the company …

Articles about Asuragen's Series A - II Round: